Cécile Tomowiak

Also affiliated with Université de Poitiers, Centre Hospitalier Universitaire de Poitiers

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A

0Author DataRank · unranked

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Humoral response to mRNA anti–COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia”.

Humoral response to mRNA anti–COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia

Blood Advances(2022)10.1182/bloodadvances.2021006215

N/A

0.596DataRank · unranked

52 citations

Rémi Letestu, Chadi Al-Nawakil, Ségolène Brichler, Vincent Lévy, Nanthara Sritharan +21 more

Expert Opinion on Managing Adverse Reactions Associated With Acalabrutinib Therapy: A Delphi Consensus From France

Clinical Lymphoma Myeloma and Leukemia(2025)10.1016/j.clml.2024.10.013

N/A

0.165DataRank · unranked

2 citations

Stéphane Ederhy, Véronique Leblond, Stéphanie Malartre, Anaïs Portalier, Vincent Sibaud +3 more